For the past 5 years, many investigators have suggested that psychiatrists are on the verge of using genotyping to guide clinical psycho-pharmacological practice. After much anticipation, the first applications of this new technology are being used to select psychotropic medication and inform individual variation in the appropriate dose of medication. Not surprisingly, the drug-metabolizing enzyme genes have been the first genes to be clinically genotyped for psychiatric practice.
PDF full text from Publisher